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Abstract
Objectives: To evaluate whether genes that encode CagA-interacting molecules (SRC, PTPN11, CRK, CRKL, CSK, c-MET and
GRB2) are associated with gastric cancer risk and whether an interaction between these genes and phytoestrogens modify
gastric cancer risk.
Methods: In the discovery phase, 137 candidate SNPs in seven genes were analyzed in 76 incident gastric cancer cases and
322 matched controls from the Korean Multi-Center Cancer Cohort. Five significant SNPs in three genes (SRC, c-MET and
CRK) were re-evaluated in 386 cases and 348 controls in the extension phase. Odds ratios (ORs) for gastric cancer risk were
estimated adjusted for age, smoking, H. pylori seropositivity and CagA strain positivity. Summarized ORs in the total study
population (462 cases and 670 controls) were presented using pooled- and meta-analysis. Plasma concentrations of
phytoestrogens (genistein, daidzein, equol and enterolactone) were measured using the time-resolved fluoroimmunoassay.
Results: SRC rs6122566, rs6124914, c-MET rs41739, and CRK rs7208768 showed significant genetic effects for gastric cancer
in both the pooled and meta-analysis without heterogeneity (pooled OR=3.96 [95% CI 2.05–7.65], 1.24 [95% CI=1.01–1.53],
1.19 [95% CI=1.01–1.41], and 1.37 [95% CI=1.15–1.62], respectively; meta OR=4.59 [95% CI 2.74–7.70], 1.36 [95% CI=1.09–
1.70], 1.20 [95% CI=1.00–1.44], and 1.32 [95% CI=1.10–1.57], respectively). Risk allele of CRK rs7208768 had a significantly
increased risk for gastric cancer at low phytoestrogen levels (p interaction,0.05).
Conclusions: Our findings suggest that SRC, c-MET and CRK play a key role in gastric carcinogenesis by modulating CagA
signal transductions and interaction between CRK gene and phytoestrogens modify gastric cancer risk.
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Introduction
Helicobacter pylori (H. pylori), a group I human gastric carcinogen by
the International Agency for Research on Cancer (IARC) [1], is the
strongestrisk factor inthe gastric cancer development,and persistent
H.pyloriinfectionisthefirststeptowardsgastriccarcinogenesis[1–3].
In spite of numerous evidence that H. pylori plays a crucial role in
gastric carcinogenesis, only a small portion of infected people
develop gastric cancer. This implies that other factorsinvolved inthe
pathogenic mechanism of H. pylori can modify individual suscepti-
bility for gastric cancer. Our previous studies demonstrated H. pylori
infection itself was not associated with the gastric cancer risk but
specifically CagA positive H. pylori infection significantly increased
risk for gastric cancer by 3.57-fold [4,5].
Cytotoxin-associated gene A (CagA), an immunodominant
protein secreted by H. pylori, appears to be one of the pathogenic
modifying factors [6–8]. After infecting H. pylori into gastric
epithelial cells, CagA acts as a major carcinogenic and virulent
component through sequential CagA signal transduction pathway.
The first step begins with the interaction between CagA and
diverse proteins such as SRC, SHP2, CRK, CRKL, and CSK
after phosphorylation and c-MET and GRB2 without phosphor-
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kinases interacts with SHP2 tyrosine phosphatase (encoded by the
PTPN11 oncogene), CRK, CRKL and CSK and induces cell
scattering, dissociation and mortality connected to cancer
development [8,12–15]. Additionally, non-phosphorylated CagA
interacts with c-MET and GRB2 which promotes oncogenic
response including cell proliferation and morphological changes
such as hummingbird formation [8,16–19]. This CagA transloca-
tion and its cellular interaction with those proteins can be a crucial
initiating step in gastric carcinogenesis [9–12].
Cellular alteration in the CagA positive H. pylori pathogenic
mechanism appears to explain different susceptibility of gastric
cancer among H. Pylori infected persons. Since cellular functions
can be regulated by their host genes, genetic variants related to the
CagA interacting molecules may be the key for individual gastric
cancer susceptibility. Based on the putative genetic differences, we
hypothesized that genes which encode CagA-interacting proteins
may modify risk for gastric cancer. Moreover, we focused on
phytoestrogens as an effect modifier in the CagA signal
transduction process. Studies have reported that phytoestrogens
with anti-inflammatory, anti-bacterial and anti-oxidant properties
can inhibit H. pylori activity and gastric cancer cell growth and
proliferation [20–22]. Especially, genistein, one of phytoestrogens
and phosphotyrosine kinase inhibitors, is reported to be an
effective blocker for CagA phosphorylation [23].
To evaluate the hypotheses, a two-stage genetic analysis that
focused on genes which directly encode CagA-binding molecules,
SRC, PTPN11, CRK, CRKL, CSK, c-MET and GRB2, was
conducted that included: 1) the discovery phase that screened
and identified single nucleotide polymorphisms (SNPs) with a
significant genetic association on gastric cancer; 2) the extension
phase that re-analyzed the most significant SNPs in the discovery
phase. Additionally, in a sub-analysis, we evaluated the gene-
environment interaction to determine whether phytoestrogen
levels modify the association between gene polymorphisms which
directly encode CagA-binding molecules and risk of gastric cancer.
Methods
Ethics Statement
The study protocols were approved by the Institutional Review
Board of Seoul National University Hospital (H-0110-084-002 for
the KMCC study and C-0910-049-297 for the current nested
case-control study) and by the Institutional Review Board of
Hanyang University Hospital (2003–4). Moreover, all participants
signed an informed consent form before entering the studies.
Study population
Two-phase genetic association study was conducted. The nested
case-controlstudy populationwas recruited from the Korean Multi-
Center Cancer Cohort (KMCC). Detailed information about the
KMCC is described elsewhere [24]. Briefly, participants were
recruited from four urban and rural areas (Haman, Chungju, Uljin,
and Youngil) in Korea. Information on individual characteristics
including general lifestyle and environmental exposure was
collected using standardized interview-based questionnaires. Blood
and spot urine samples were also collected. All participants were
passively followed-up through computerized record linkages to the
national cancer registry, the national death certificate, and the
health insurance medical records. The passive follow-up methods
of the KMCC have been reported to be highly efficient and
complete [25].
On December 2002, a total of 136 gastric cancer cases defined
according to the International Statistical Classification of Diseases
and Related Health Problems 10th Revision (ICD-10, C16) were
identified in the discovery phase. Among them, 84 cases excluding
cases diagnosed before recruitment (n=36) and without blood
samples (n=16) were initially selected for genotyping. Four
cancer-free controls (n=336) were matched to each gastric cancer
case by incidence density sampling based on age (65 years), sex,
residential district, and enrollment year. Eight cases and 14
controls were excluded due to poor genotyping performance, and
thus, 76 cases and 322 controls were included in the discovery
phase.
In the extension phase, 388 gastric cancer case-control sets were
selected as follows: 1) 334 gastric cancer cases including 136 cases
identified on December 31, 2002 were ascertained from the
KMCC in December 31, 2008. Excluding the cases analyzed in
the discovery phase (N=84) and without blood samples (N=51),
199 gastric cancer cases were matched 1:1 to controls according to
age (65 years), sex, and enrollment year. 2) 189 newly diagnosed
gastric cancer cases at Chungnam University Hospital and
Hanyang University GURI Hospital with informed consent were
recruited from March 2002 to September 2006. Blood samples
were collected at the time of diagnosis or prior to gastric cancer
surgery. Additionally, 189 community-based controls matched by
age (65 years), sex and enrollment year (from 2001 to 2005) were
randomly selected from the KMCC. Of the 388 gastric cancer
case-control matches, two cases and 40 controls were eliminated
due to poor genotyping and insufficient sample and finally, 386
cases and 348 controls were analyzed in the extension phase.
Candidate genes and SNP selection
In the CagA signal transduction pathway, CagA directly binds
to seven proteins that lead to sequential processes. Host genes
encoding the seven proteins were selected as follows: v-Crk
sarcoma virus CT10 oncogene homolog (CRK); v-Crk sarcoma
virus CT10 oncogene homolog (avian)-like (CRKL); c-Src tyrosine
kinase (CSK); growth factor receptor-bound protein 2 (GRB2); Met
proto-oncogene (c-MET); nuclear factor of activated T-cells,
protein tyrosine phosphatase, non-receptor type 11 (PTPN11)
encoding SHP2 tyrosine phosphatase and v-Src sarcoma
(Schmidt-Ruppin A-2) viral oncogene homolog (SRC).
Candidate SNPs were selected according to the three criteria:
SNPs reported to have 1) a possible functional relevance for cancer
in previous studies; 2) minor allele frequency (MAF) .0.05 in
Asian population in public databases such as SNP500Cancer or
the international HapMap project using dbSNP IDs (http://www.
ncbi.nlm.nih.gov/snp); and concurrently 3) MAF .0.05 in
Japanese (JET) in the international HapMap project. Finally,
137 SNPs with a design score=1.1 and r
2.0.8 were genotyped to
screen the significant SNPs for gastric cancer risk. 108 SNPs are
located in the intron region; 24 SNPs are located in the promoter
region (flanking region or UTR); five SNPs are located in the
coding region.
Genotyping
In the discovery phase, 137 SNPs in seven candidate genes
encoding CagA interacting proteins were genotyped. After
measuring concentrations of genomic DNA for all study subjects
by a spectrophotometer (NanoDrop ND-1000, NanoDrop Tech-
nologies), genotyping was performed using GoldenGate
TM assay
(IlluminaH, San Diego, CA, USA). To ensure quality control and
evaluate the intra-subject concordance rate, 52 duplicate samples
were randomly distributed in the genotyping plate. Concordance
rates for all assays were greater than 99%. Of the 137 SNPs, 21
SNPs were dropped out due to failure of genotyping (4 SNPs),
SNP call rate ,90% (7 SNPs), HWE ,0.0001 (1 SNPs) and MAF
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due to genotyping call rate ,90%. Finally, 116 SNPs in seven
genes (genotyping rate of 99.6%) in 76 cases and 322 controls were
analyzed.
In the extension phase, five SNPs with a raw p-value ,0.02, tag
SNPs or higher design scores (rs6122566 and rs6124914 in SRC;
rs41739 and rs41737 in c-MET; rs7208768 in CRK) identified in
the discovery analysis were genotyped using the Illumina
VeraCode GoldenGate Assay with BeadXpress according to the
manufacturer’s protocol (IlluminaH, USA) [26]. To ensure the
reliability of the genotyping methods in the two phases, 188
samples were genotyped twice by each method. The concordance
rate was .98.4%. Two cases and 40 controls with insufficient
DNA (n=15) or genotyping call rate ,90% (n=27) were
excluded. Finally, five SNPs in three genes (genotyping rate of
99.6%) were analyzed in 386 cases and 348 controls.
H. pylori infection and CagA seropositivity
H. pylori infection and CagA seropositivity were evaluated using
immunoblot assay, Helico Blot 2.1
TM (MP Biomedicals Asia
Pacific, Singapore). Helico Blot 2.1
TM kits have been reported to
have high sensitivity and specificity (for sensitivity, 99% identically
in both; for specificity, 98% and 90%, respectively) [27].
Measurements of Phytoestrogen biomarkers
Plasma concentrations of four phytoestrogen biomarkers that
were 1) isoflavones: genistein, daidzein, and equol (daidzein
metabolite) and 2) lignan: enterolactone were measured using
time-resolved fluoroimmunoassay kits (Labmaster, Finland). After
free phytoestrogen biomarkers were extracted from 200 mLo f
plasma sample, the VICTOR3
TM 1420 Multilabel Counter
measured time-resolved fluorescence (Perkin-Elmer). Detailed
measurement methods for phytoestrogen biomarkers are described
elsewhere [28]. Of the total study population, plasma concentra-
tions of the four biomarkers were measured in 406 cases and 417
controls with sufficient plasma volume (.200 mL).
Statistical analysis
To compare the basic characteristics between gastric cancer
cases and controls, the chi-square test and Student t-test were
conducted. P-values for difference in proportion for sex, age, H.
pylori infection, CagA and VacA seropositivity, cigarette smoking,
alcohol drinking, and gastritis history between cases and controls
were determined.
Hardy-Weinberg equilibrium (HWE) in the control group was
evaluated using the chi-square test or Fisher’s exact test with a cut-
off level of HWE ,0.0001. In the discovery phase, minimum global
p-values (p,0.05) in the likelihood ratio test (LRT) with 1 degree of
freedom (df) in the additive model and LRT with 2 df in the
genotypic model were calculated to select significant SNPs. Using
three genetic models, additive, recessive and dominant models, the
association between the selected SNPs and gastric cancer risk was
analyzed. Permutated p-values were estimated by 100,000 permu-
tationtestsinthe single SNPanalysis.Toavoidspuriousassociations
with false positive outcomes, the corrected permutated p-values on
the condition of multiple SNPs and the false discovery rate (FDR)
using a Benjamini-Hochberg Method were computed [29]. Gastric
cancer risk was estimated as odds ratios (ORs) and 95% confidence
intervals (CIs) using unconditional logistic regression model
adjusting for risk factors that were age, smoking status (ever vs.
never), H. pylori infection (positive vs. negative) and CagA
seropositivity (positive vs. negative). Additionally, haplotype analysis
was performed for genes containing significantly associated SNPs
from an individual SNP analysis using Haploview 4.1 software
(www.broad.mit.edu/mpg/haploview/).
In the extension phase, the most significant SNPs identified in the
discovery phase were re-evaluated. Based on the additive or
recessive models, gastric cancer risk was estimated as ORs and 95%
CIs using unconditional logistic regression model adjusting for the
same covariates mentioned above. To summarize the results from
the discovery and the extension phases, pooled- and meta-analysis
wereconducted.Usingthefixedeffect model,summarizedORsand
95% CIs were computed. Also, heterogeneity across the studies was
evaluated by the Cochran Q statistics [30].
Using analysis of variance and covariance (ANCOVA) with age,
smoking status (ever vs. never), H. pylori infection (positive vs.
negative) and CagA seropositivity (positive vs. negative) as potential
risk factors for gastric cancer, the means of the phytoestrogen
biomarker levels between cases and controls were compared.
Stratified analysis by high and low levels of phytoestrogen
biomarkers (genistein, daidzein, equol and enterolactone) where
the cut-off levels were determined by the Spline analysis was
conducted using unconditional logistic regression models. Inter-
action effects between the most significant SNPs and phytoestro-
gen biomarkers were also computed as ORs and 95% CIs adjusted
for age, smoking status (ever vs. never), H. pylori infection (positive
vs. negative) and CagA seropositivity (positive vs. negative).
All statistical analyses were performed using SAS software
version 9.2 (SAS Institute, Cary, North Carolina), and PLINK
software version 1.07 (http://pngu.mgh.harvard.edu/purcell/
plink) [31]. Meta-analyses were conducted using STATA version
10 (Stata, College Station, TX).
Results
There was no significant difference between cases and controls
according to sex, H. pylori infection, CagA/VacA seropositivity,
smoking/drinking status and gastric ulcer history in the discovery
and extension phases (p.0.05). CagA/VacA seropositivity and the
proportion of current smokers were significantly higher among
gastric cancer cases in the pooled data (p=0.03, p,0.01, p=0.02,
respectively) (Table S1).
Of the 116 SNPs in the seven candidate genes encoding CagA
interacting proteins analyzed in the discovery phase, 22 SNPs in
three genes, SRC, c-MET, and CRK, were significantly associated
with gastric cancer (p-LRT,0.05). SRC rs6122566 significantly
increased risk for gastric cancer in the recessive models
(OR=4.90, [95% CI 1.19–14.2]). Thirteen SNPs that were
rs41739, rs16945, rs41738, rs6566, rs10435378, rs41737,
rs2023748, rs41736, rs41735, rs6951311, rs183642, rs2237717
and rs38859 in c-MET gene showed a significant gene-dose effect
in the linear trend tests (p,0.05). CRK rs7208768 had a marginally
significant gene-dose effect. 100,000 permutation tests in the single
SNP analysis showed SRC rs6122566, c-MET rs41739 and CRK
rs7208768 with the most significant permutated p-value in each
gene (ppermutation=0.00284, ppermutation=0.00989, ppermutation=
0.01392, respectively). The marginal significance of the corrected
permutated p-value was observed for SRC rs6122566 (p=0.0918)
but all FDR p-values in all genetic models were not significant
(p.0.2) (Table S2).
Haplotype blocks were identified by the LD plot (Figure S1).
The largest block was constructed with the most significant SNPs
including rs41739, rs6566, and rs41738, but the omnibus p-value
was not significant (p.0.05). Four blocks defined by SRC and one
block defined by CRK did not show statistical significance in the
omnibus test. The results of the haplotype analysis did not present
information beyond individual SNP results (data not shown).
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SRC gene and rs7208768 in CRK remained significantly associated
with an increased risk for gastric cancer (OR=4.01, [95% CI:
1.62–9.96]; OR=1.30, [95% CI: 1.00–1.70]; OR=1.33, [95%
CI: 1.08–1.64], respectively). Associations between the SNPs in c-
MET gene (rs41739 and rs41737) and gastric cancer risk were
attenuated. In the combined analysis that included the discovery
and extension phases, the risk estimate of SRC rs6122566 in the
recessive model was significantly associated with gastric cancer in
both the pooled and meta-analyses (OR=3.96, [95% CI: 2.05–
7.65]; OR=4.59, [95% CI: 2.74–7.70], respectively). Moreover,
SRC rs6124914, c-MET rs41739 and CRK rs7208768 showed
significant gene-dose effects for gastric cancer in both analyses.
There was no heterogeneity across the analyses (Cochran Q test,
p.0.05) (Table S3).
Among a total of 823 subjects (406 cases and 417 controls) who
were measured the plasma levels of the four phytoestrogen
biomarkers, the overall concentrations of genistein, daidzein and
enterolactone in cases were significantly lower than those of the
controls (genistein 167.6 nmol/L in cases vs. 200.2 nmol/L in
controls, p=0.0004; daidzein 91.4 nmol/L in cases vs.
131.6 nmol/L in controls, p,0.0001; enterolactone 51.0 nmol/L
in cases vs. 77.7 nmol/L in controls, p,0.0001). Overall plasma
concentrations of equol, a daidzein metabolite, were lower in cases
but not statistically significant (50.3 nmol/L for cases vs.
62.2 nmol/L for controls; p=0.0977). In stratified analysis
according to phytoestrogen biomarkers, a significant gene-
environment interaction was observed in CRK. Risk allele of
CRK rs7208768 had a significantly increased risk for gastric cancer
at low phytoestrogen levels. Specifically, the A allele of rs7208768
was associated with a greater risk of gastric cancer at low genistein,
daidzein, equol and enterolactone and statistically significant
(OR=1.91, [95% CI: 1.44–2.52] at low genistein; OR=2.09,
[95% CI: 1.46–3.01] at low daidzein; OR=1.87, [95% CI: 1.26–
2.78] at low equol; OR=1.77, [95% CI: 1.10–2.85] at low
enterolactone). The p-interaction was significant (p=0.0001,
p=0.0013, p=0.0147, p=0.0404, respectively) (Table S4).
Though additional stratified analyses were also conducted to
detect an interaction between CagA seropositivity and each gene
effect for gastric cancer risk, interactions were not significant in
any of the three genes, SRC, c-MET and CRK (data not shown).
Discussion
CagA-secreting H. pylori infection appears to play an important
role in gastric carcinogenesis via sequential CagA signal
transduction pathway. CagA initially binds to seven protein
components to activate aberrant cellular responses that underlie
the development of gastric cancer. Since function of the protein
can be regulated by their host genes, genes that encode CagA
interacting molecules may be able to modify risk for gastric cancer.
To evaluate this hypothesis, we genotyped 137 SNPs in seven
candidate genes and demonstrated that genetic variants of SRC
(rs6122566 and rs6124914), c-MET (rs41739) and CRK
(rs7208768) were significantly associated with gastric cancer risk.
Additionally, an interactive effect of CRK genetic polymorphism,
rs7208768, and four phytoestrogen biomarkers, genistein, daid-
zein, equol and enterolactone on gastric cancer risk were analyzed.
SRC, a non-receptor protein tyrosine kinase (TK), appear to be
essential in gastric carcinogenesis. Once injected into gastric
epithelial cells, CagA undergoes tyrosine phosphorylation by the
SRC family kinases [8,12,18]. The tyrosine phosphorylation of
CagA is an integral step in determining the sequential cellular
signaling mechanism. Because some CagA interacting molecules
such as SHP-2, CRK and CSK are only able to respond with
phosphorylated CagA, SRC can be more important in influencing
other’s cellular functions and inducing development of gastric
cancer. Additionally, SRC has been reported to play a crucial role
in tumor progression and mediate cancer development and
metastasis [32]. Cellular activity of SRC appears to be altered
by the host gene and our results indicate that SRC rs6122566 and
rs6124914 can be risk modifiers in gastric carcinogenesis. SRC
genetic variations that influence the cellular capacity in gastric
epithelial cells are associated with gastric cancer risk.
Despite the attenuated significance in the extension analysis, c-
MET which is synonymous with HGFR (hepatocyte growth factor
receptor) may be an independent risk gene for gastric cancer.
Numerouspreviousstudiesreportedthatc-MET,oneofthereceptor
TKs, promotes invasive tumor growth, cell invasion, and mortality,
and amplification and/or overexpression of c-MET was associated
with various human carcinoma including gastric cancer [17,33–36].
In terms of c-MET cellular mechanism, CagA plays a role as an
adaptor protein, Gab, to mediate receptor TK signaling by
controlling a cluster of downstream components at the activated
receptor such as Grb2, PLCc, and SHP-2 [37,38]. By functionally
mimicking the Gab adaptor protein, CagA might stimulate
abnormal proliferation and mortality of gastric epitherial cells [39].
In the present study, a polymorphism of c-MET gene (rs41739) was
significantly associated with gastric cancer risk and a possible genetic
susceptible factor on gastric cancer. Consistent with the cellular
importance and function, c-MET gene appears to modify the risk for
gastric carcinogenesis through CagA signal transduction pathway.
CRK adaptor protein which has splicing isoforms, CRK-I
(SH2-SH3) and CRK-II (SH2-SH3-SH3), binds to TKs and
controls transcription and cytoskeletal reorganization modulating
cellular activities [40]. Also, this adaptor protein integrates various
cellular signals and its dysregulation is connected to the human
carcinoma [41]. Interaction between CRK and phosphorylated
CagA has been reported to be a biological prerequisite that leads
to morphological change, cell scattering and deregulation of cell–
cell adhesion in the gastric epithelium [14]. Several studies have
indicated that overexpression of CRK is associated with various
types of human cancers including lung, gastric and colon cancer
[42,43]. Our findings also support the genetic potential of CRK
rs7208768 on the development of gastric cancer and both genetic
and cellular magnitude of CRK.
More interestingly, significant interactions between the CRK
genetic polymorphism and four phytoestrogen biomarkers, genis-
tein,daidzein,equoland enterolactone,modified gastriccancerrisk.
Studies indicated protective effects of phytoestrogens on gastric
cancer [20,28] and particularly, genistein inhibited the ERK signal
transduction cascade induced by H. pylori infection playing a role as
a tyrosine kinase inhibitor [44]. Considering CRK is the major
upstream molecule of ERK activation, the risky genetic variants of
CRK to activate the ERK signaling can be blocked by phytoestro-
gens, and mediate the development of gastric cancer.
SRC, c-MET and CRK are also involved in the protein TKs
that is a diverse multigene family which controls cellular signal
transduction pathway mediating a range of downstream cellular
processes and plays significant roles in the development of various
clinical diseases [45,46]. TKs are also known as oncogenes
involved in human malignancies. SRC belongs to a non-receptor
TK and c-MET is a receptor TK, while CRK is an adaptor
protein which binds to TK-phosphorylated proteins and strength-
ens the main proteins in the signal transduction pathway [41].
These three molecules encoded by SRC, c-MET, and CRK genes
can independently induce cell differentiation, adhesion, death and
morphological changes by transmiting cell signals related to their
CagA-Related Genes, Phytoestrogen & Gastric Cancer
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genes related to TK action appear to play a crucial role as a
susceptible factor for gastric cancer considering genistein that is a
tyrosine kinase inhibitor can reduce gastric cancer risk [28]. This
indicates that genetic susceptibilities of SRC, c-MET, and CRK in
gastric carcinogenesis should be treated as independent risk factors
that modify the cellular signal transduction in TK dependent
manners because uninfected persons with CagA secreting H. Pylori
can be at risk for gastric cancer depending on individual genetic
variants of the three genes.
Though PTPN11, CRKL, CSK, and GRB2 did not show any
significant association with gastric cancer in the present study,
their genetic effects should not be overlooked. At the cellular level,
these molecules are significantly related to aberrant effects that
underlie gastric carcinogenesis [12]. As one of the human proto-
oncogenes, PTPN11 encodes cytoplasmic tyrosine phosphatase
with SHP2 and can induce aberrant hyperactivation of the ERK
signaling [47]. A study has also reported that a PTPN11 genetic
variant increased the risk for gastric atrophy and cancer among
CagA positive H. pylori infected people [48]. In the CagA signal
transduction pathway, CRKL works quite similarly to CRK; CSK
frustrates an activity of SRC family kinase and CagA-SHP2
signaling; and GRB2 acts as a trigger to activate the RAS/MEK/
ERK pathway [14,18,49]. Further studies with a greater number
of gastric cancer cases and wider coverage of genetic polymor-
phisms in these genes are warranted.
Gastric carcinogenesis induced by CagA positive H. Pylori
infection can be infered from our study results and review of
cellular mechanisms [16,18,47] (Figure S2). Once CagA is injected
in gastric ephithelial cells, SRC initiates CagA phosphorylation
that interacts with CRK adaptor protein and SHP2 to promote
the ERK activation. Non-phosphorylated CagA mimics the Gab
adaptor protein to potentiate the c-MET-HGF intracellular
signaling and stimulate c-MET signals that also activates the
ERK signal cascade. As a result, CagA binding molecules such as
SRC, c-MET, CRK, SHP2, CRKL and GRB2 interacts with
phosphorylated or non-phosphorylated CagA to stimulate down-
stream signals in the ERK activation inducing oncogenic effects on
gastric cancer, whereas, CSK inhibits SRC family kinase functions
and CagA-SHP2 signaling effects. In terms of genetic mechanism,
significant genetic markers of SRC (rs6122566 and rs6124914), c-
MET (rs41739) and CRK (rs7208768) are actively involved in
gastric carcinogenesis. Interestingly, primary interacting mole-
cules, SRC, c-MET, CRK and SHP2, contribute to mutual
development and sequentially connect to operate carcinogenic
effect. In particular, SRC can extensively influence the activity of
the others from migration to signal transduction [11,50].
We examined SNPs from our other study that used the
Affymetrix 5.0 platform and the Korea Centers for Disease
Control and Prevention (KCDC) study that used the Affymetrix
6.0 platform to find consistencies. In the KCDC study, SRC
rs6122566 which was the most significant SNP in the present study
showed a raw p-value of 0.0009 in the single SNP analysis.
Unfortunately, many other significant SNPs were not included in
the platforms due to different SNP selection methods (random
SNPs vs. candidate SNPs according to MAF .0.05 in Asians) and
target populations (Caucasian vs. Koreans). Nevertheless, our
results might be applicable to most East-Asian populations because
the minor allele frequencies of our significant SNPs showed
similarities to other Asian populations such as Chinese and
Japanese (http://www.hapmap.org) (Appendix S1).
Limitations should be noted. First, due to the restricted number
of study subjects, we did not have sufficient statistical power and
were not able to perform subgroup analyses for gastric cancer
types such as histological (intestinal vs. diffuse) and anatomical
subtypes (cardia vs. non-cardia). Second, we only focused on CagA
interacting molecules and thus, secondary interacting molecules in
CagA downstream signaling pathways such as RAS and ERK
cascade were not included in this study. Third, in the extension
phase, selection bias may be induced because hospital-based cases
were matched to community-based controls. However, consider-
ing that 1) genetic traits are inborn and not easily changeable, 2)
all cases were matched to controls according to the major
covariates in the initial study design stage, 3) effects of confounding
factors were considered by the use of multivariable models, and 4)
no heterogeneity between hospital- and community-based cases in
meta-analysis, the potential selection bias may be minimized.
In spite of the limitations, this is a two-phase genetic association
study that provides evidence on the role of CagA cellular
mechanism-related genes. Through the candidate approach of
the discovery phase, the most significant SNPs were preliminarily
screened and after, the SNPs were re-evaluated in the extension
phase. Moreover, through intensive analyses that focused on gene
and gene-environment interaction, conclusive evidence is provided
to elucidate the etiology of gastric cancer.
This study shows SRC, c-MET, and CRK genetic variants can be
susceptible genetic factors for the development of gastric cancer by
controlling signals through the CagA transduction pathways.
Moreover, an interaction between CRK genetic polymorphism and
phytoestrogen biomarkers appear to play a role as risk modifiers in
gastric carcinogenesis. Replication studies with a greater number
of cases and more substantial genomic coverage of the genes will
allow us to elucidate gastric cancer pathological mechanisms based
on the CagA signal transduction.
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(TIF)
Table S1 Basic characteristics of gastric cancer cases
and controls in the genetic analysis: discovery, extension
and pooled analyses.
(DOC)
Table S2 Significant SNPs for genes which directly
encode CagA-binding molecules associated with gastric
cancer in the discovery phase.
(DOC)
CagA-Related Genes, Phytoestrogen & Gastric Cancer
PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31020Table S3 Association between representative SNPs in
CagA-binding molecules and gastric cancer risk.
(DOC)
Table S4 The gastric cancer risk associated with the
interaction between SNPs in CagA-binding molecules
and phytoestrogens.
(DOC)
Author Contributions
Conceived and designed the experiments: SKP JJY LYC DK KYY.
Performed the experiments: JJY LYC KPK SHM. Analyzed the data: JJY
SKP AS. Contributed reagents/materials/analysis tools: BYC DSH KSS
YSK JYL BGH SHC HRS KYY. Wrote the paper: JJY LYC SKP.
References
1. International Agency for Research on Cancer (IARC) (1994) IARC Monographs
on the evaluation of carcinogenic risks to human: Schistosomes, liver flukes and
Helicobacter pylori. Lyon, France: IARC Press. pp 177–240.
2. Blaser MJ (1998) Helicobacter pylori and gastric diseases. BMJ 316: 1507–1510.
3. Hatakeyama M, Higashi H (2005) Helicobacter pylori CagA: a new paradigm
for bacterial carcinogenesis. Cancer Sci 96: 835–843.
4. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, et al. (2006) CagA-producing
Helicobacter pylori and increased risk of gastric cancer: a nested case-control
study in Korea. Br J Cancer 95: 639–641.
5. Shin A, Shin HR, Kang D, Park SK, CS K, et al. (2005) A nested case-control
study of the association of Helicobacter pylori infection with gastric
adenocarcinoma in Korea. Br J Cancer 92: 1273–1275.
6. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, et al. (1995)
Infection with Helicobacter pylori strains possessing cagA is associated with an
increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:
2111–2115.
7. Parsonnet J, Friedman GD, Orentreich N, Vogelman H (1997) Risk for gastric
cancer in people with CagA positive or CagA negative Helicobacter pylori
infection. Gut 40: 297–301.
8. Hatakeyama M (2006) The role of Helicobacter pylori CagA in gastric
carcinogenesis. Int J Hematol 84: 301–308.
9. Fischer W, Pu ¨ls J, Buhrdorf R, Gebert B, Odenbreit S, et al. (2001) Systematic
mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes
for CagA translocation in host cells and induction of interleukin-8. Mol
Microbiol 42: 1337–1348.
10. Rohde M, Pu ¨ls J, Buhrdorf R, Fischer W, Haas R (2003) A novel sheathed
surface organelle of the Helicobacter pylori cag type IV secretion system. Mol
Microbiol 49: 219–234.
11. Handa O, Naito Y, Yoshikawa T (2007) CagA protein of Helicobacter pylori: a
hijacker of gastric epithelial cell signaling. Biochem Pharmacol 73: 1697–1702.
12. Wen S, Moss SF (2009) Helicobacter pylori virulence factors in gastric
carcinogenesis. Cancer Lett 282: 1–8.
13. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S (2002) Src is the kinase
of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 277:
6775–6778.
14. Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, et al. (2005) Interaction
of CagA with Crk plays an important role in Helicobacter pylori-induced loss of
gastric epithelial cell adhesion. J Exp Med 202: 1235–1247.
15. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M (2003)
Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction
between CagA and C-terminal Src kinase. J Biol Chem 278: 3664–3670.
16. Ando T, Goto Y, Ishiguro K, Maeda O, Watanabe O, et al. (2007) The
interaction of host genetic factors and Helicobacter pylori infection. Inflammo-
pharmacology 15: 10–14.
17. Gentile A, Trusolino L, Comoglio PM (2008) The Met tyrosine kinase receptor
in development and cancer. Cancer Metastasis Rev 27: 85–94.
18. Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA
protein. Nat Rev Cancer 4: 688–694.
19. Porter J (2010) Small molecule c-Met kinase inhibitors: a review of recent
patents. Expert Opin Ther Pat 20: 159–177.
20. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, et al. (1993) Genistein
arrests cell cycle progression at G2-M. Cancer Res 53: 1328–1331.
21. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q (2004) Apoptosis of human
primary gastric carcinoma cells induced by genistein. World J Gastroenterol 10:
1822–1825.
22. Hong H, Landauer MR, Foriska MA, Ledney GD (2006) Antibacterial activity
of the soy isoflavone genistein. J Basic Microbiol 46: 329–335.
23. Odenbreit S, Pu ¨ls J, Sedlmaier B, Gerland E, Fischer W, et al. (2000)
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV
secretion. Science 287: 1497–1500.
24. Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, et al. (2002) Korean Multi-
center Cancer Cohort Study including a Biological Materials Bank (KMCC-I).
Asian Pac J Cancer Prev 3: 85–92.
25. Cho LY, Kim CS, Li L, Yang JJ, Park B, et al. (2009) Validation of self-reported
cancer incidence at follow-up in a prospective cohort study. Ann Epidemiol 19:
644–646.
26. Lin CH, Yeakley JM, McDaniel TK, Shen R (2009) Medium- to high-
throughput SNP genotyping using VeraCode microbeads. Methods Mol Biol
496: 129–142.
27. Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, et al. (2002) New
serological assay for detection of putative Helicobacter pylori virulence factors.
J Clin Microbiol 40: 4753–4756.
28. Ko KP, Park SK, Park B, Yang JJ, Cho LY, et al. (2010) Isoflavones from
phytoestrogens and gastric cancer risk: a nested case-control study within the
Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev 19:
1292–1300.
29. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J Roy Stat Soc B 57: 289–300.
30. Hardy RJ, Thompson SG (1998) Detecting and describing heterogeneity in
meta-analysis. Stat Med 17: 841–856.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
32. Summy JM, Gallick GE (2003) Src family kinases in tumor progression and
metastasis. Cancer Metastasis Rev 22: 337–358.
33. Ma PC, Tretiakova MS, MacKinnon AC, Ramnath N, Johnson C, et al. (2008)
Expression and mutational analysis of MET in human solid cancers. Genes
Chromosomes Cancer 47: 1025–1037.
34. Inoue T, Kataoka H, Goto K, Nagaike K, Igami K, et al. (2004) Activation of c-
Met (hepatocyte growth factor receptor) in human gastric cancer tissue. Cancer
Sci 95: 803–808.
35. Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, et al. (2003) c-MET
expression level in primary colon cancer: a predictor of tumor invasion and
lymph node metastases. Clin Cancer Res 9: 1480–1488.
36. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, et al. (1992) Frequent
amplification of the c-met gene in scirrhous type stomach cancer. Biochem
Biophys Res Commun 189: 227–232.
37. Gual P, Giordano S, Williams TA, Rocchi S, Van Obberghen E, et al. (2000)
Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-
induced branching tubulogenesis. Oncogene 19: 1509–1518.
38. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ (1996)
A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
Nature 379: 560–564.
39. Hatakeyama M (2003) Helicobacter pylori CagA - a potential bacterial
oncoprotein that functionally mimics the mammalian Gab family of adaptor
proteins. Microbes Infect 5: 143–150.
40. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, et al. (2007)
Structural basis for the transforming activity of human cancer-related signaling
adaptor protein CRK. Nat Struct Mol Biol 14: 503–510.
41. Birge RB, Kalodimos C, Inagaki F, Tanaka S (2009) Crk and CrkL adaptor
proteins: networks for physiological and pathological signaling. Cell Commun
Signal 7.
42. Nishihara H, Tanaka S, Tsuda M, Oikawa S, Maeda M, et al. (2002) Molecular
and immunohistochemical analysis of signaling adaptor protein Crk in human
cancers. Cancer Lett 180: 55–61.
43. Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, et al. (2003) Increased
C-CRK proto-oncogene expression is associated with an aggressive phenotype in
lung adenocarcinomas. Oncogene 22: 7950–7957.
44. Chen YC, Wang Y, Li JY, Xu WR, Zhang YL (2006) H. pylori stimulates
proliferation of gastric cancer cells through activating mitogen-activated protein
kinase cascade. World J Gastroenterol 12: 5972–5977.
45. Robinson DR, Wu YM, Lin SF (2000) The protein tyrosine kinase family of the
human genome. Oncogene 19: 5548–5557.
46. Porter J (2010) Small molecule c-Met kinase inhibitors: a review of recent
patents. Expert Opin Ther Pat 20: 159–177.
47. Chan RJ, Feng GS (2007) PTPN11 is the first identified proto-oncogene that
encodes a tyrosine phosphatase. Blood 109: 862–867.
48. Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, et al. (2006)
Association between serum pepsinogens and polymorphismof PTPN11 encoding
SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 118:
203–208.
49. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, et al. (2002) Grb2 is a key
mediator of helicobacter pylori CagA protein activities. Mol Cell 10: 745–755.
50. Herynk MH, Zhang J, Parikh NU, Gallick GE (2007) Activation of Src by c-Met
overexpression mediates metastatic properties of colorectal carcinoma cells. J Exp
Ther Oncol 6: 205–217.
CagA-Related Genes, Phytoestrogen & Gastric Cancer
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31020